OVATION-3: A RANDOMIZED PHASE III TRIAL EVALUATING THE SAFETY AND EFFICACY OF INTRAPERITONEAL IL-12 GENE THERAPY ADMINISTERED IN COMBINATION WITH STANDARD NEOADJUVANT AND ADJUVANT CHEMOTHERAPY IN NEWLY DIAGNOSED PATIENTS WITH ADVANCED EPITHELIAL OVARIAN CANCER